OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diazido platinum(iv) complexes for photoactivated anticancer chemotherapy
Huayun Shi, Cinzia Imberti, Peter J. Sadler
Inorganic Chemistry Frontiers (2019) Vol. 6, Iss. 7, pp. 1623-1638
Open Access | Times Cited: 102

Showing 1-25 of 102 citing articles:

Metallodrugs are unique: opportunities and challenges of discovery and development
Elizabeth J. Anthony, Elizabeth M. Bolitho, Hannah E. Bridgewater, et al.
Chemical Science (2020) Vol. 11, Iss. 48, pp. 12888-12917
Open Access | Times Cited: 526

How promising is phototherapy for cancer?
Huayun Shi, Peter J. Sadler
British Journal of Cancer (2020) Vol. 123, Iss. 6, pp. 871-873
Open Access | Times Cited: 172

Targeting drug delivery with light: A highly focused approach
Teresa L. Rapp, Cole A. DeForest
Advanced Drug Delivery Reviews (2021) Vol. 171, pp. 94-107
Open Access | Times Cited: 128

Recent advances in the synthesis, stability, and activation of platinum(IV) anticancer prodrugs
Zoufeng Xu, Zhigang Wang, Zhiqin Deng, et al.
Coordination Chemistry Reviews (2021) Vol. 442, pp. 213991-213991
Closed Access | Times Cited: 123

What blocks more anticancer platinum complexes from experiment to clinic: Major problems and potential strategies from drug design perspectives
Kun Peng, Bing‐Bing Liang, Wenting Liu, et al.
Coordination Chemistry Reviews (2021) Vol. 449, pp. 214210-214210
Closed Access | Times Cited: 120

Recent Advances of Platinum‐Based Anticancer Complexes in Combinational Multimodal Therapy
Tianyuan Zhong, Jie Yu, Yong Pan, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 22
Open Access | Times Cited: 43

Nanomaterials‐Induced Redox Imbalance: Challenged and Opportunities for Nanomaterials in Cancer Therapy
Xumeng Wu, Ziqi Zhou, Kai Li, et al.
Advanced Science (2024) Vol. 11, Iss. 16
Open Access | Times Cited: 27

Single-Cell Chemistry of Photoactivatable Platinum Anticancer Complexes
Elizabeth M. Bolitho, Carlos Sanchez‐Cano, Huayun Shi, et al.
Journal of the American Chemical Society (2021) Vol. 143, Iss. 48, pp. 20224-20240
Open Access | Times Cited: 72

Platinum-containing heterometallic complexes in cancer therapy: advances and perspectives
Lili Ma, Luwei Li, Guangyu Zhu
Inorganic Chemistry Frontiers (2022) Vol. 9, Iss. 11, pp. 2424-2453
Closed Access | Times Cited: 62

Recent updates in nanoscale delivery systems of platinum(IV) antitumor prodrugs
Zhiyuan Zhou, Pengmin Shi, Changli Wang, et al.
Coordination Chemistry Reviews (2024) Vol. 508, pp. 215774-215774
Closed Access | Times Cited: 13

Advancements in platinum-based anticancer drug development: A comprehensive review of strategies, discoveries, and future perspectives
Debsankar Sahoo, Priya Deb, Tamal Basu, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 112, pp. 117894-117894
Closed Access | Times Cited: 12

Tuning the photoactivated anticancer activity of Pt(iv) compounds via distant ferrocene conjugation
Huayun Shi, Fortuna Ponte, Jaspreet Singh Grewal, et al.
Chemical Science (2024) Vol. 15, Iss. 11, pp. 4121-4134
Open Access | Times Cited: 11

A Photodynamic and Photochemotherapeutic Platinum‐Iridium Charge‐Transfer Conjugate for Anticancer Therapy
Huayun Shi, Oliver W. L. Carter, Fortuna Ponte, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 23
Open Access | Times Cited: 11

Leading prodrug strategies for targeted and specific release
Rupa Bargakshatriya, Sumit Kumar Pramanik
Future Medicinal Chemistry (2025), pp. 1-4
Closed Access | Times Cited: 1

BODI-Pt, a Green-Light-Activatable and Carboplatin-Based Platinum(IV) Anticancer Prodrug with Enhanced Activation and Cytotoxicity
Houzong Yao, Shu Chen, Zhiqin Deng, et al.
Inorganic Chemistry (2020) Vol. 59, Iss. 16, pp. 11823-11833
Closed Access | Times Cited: 58

Exploiting azide–alkyne click chemistry in the synthesis, tracking and targeting of platinum anticancer complexes
Nicola J. Farrer, Darren M. Griffith
Current Opinion in Chemical Biology (2020) Vol. 55, pp. 59-68
Open Access | Times Cited: 56

Induction of immunogenic cell death in cancer cells by a photoactivated platinum(iv) prodrug
Vojtěch Novohradský, Jitka Prachařová, Jana Kašpárková, et al.
Inorganic Chemistry Frontiers (2020) Vol. 7, Iss. 21, pp. 4150-4159
Open Access | Times Cited: 56

Pt(iv) antitumor prodrugs: dogmas, paradigms, and realities
Mauro Ravera, Elisabetta Gabano, Michael J. McGlinchey, et al.
Dalton Transactions (2021) Vol. 51, Iss. 6, pp. 2121-2134
Closed Access | Times Cited: 46

Photocytotoxicity and photoinduced phosphine ligand exchange in a Ru(ii) polypyridyl complex
Sean J. Steinke, Sayak Gupta, Eric J. Piechota, et al.
Chemical Science (2022) Vol. 13, Iss. 7, pp. 1933-1945
Open Access | Times Cited: 35

Platinum-Based Two-Photon Photosensitizer Responsive to NIR Light in Tumor Hypoxia Microenvironment
Yanjun Wang, Xiangchao Shi, Hongbao Fang, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 11, pp. 7786-7798
Closed Access | Times Cited: 28

Flavin-Conjugated Pt(IV) Anticancer Agents
Juan Sánchez-Camacho, Sonia Infante-Tadeo, Ana C. Carrasco, et al.
Inorganic Chemistry (2023) Vol. 62, Iss. 14, pp. 5644-5651
Open Access | Times Cited: 22

Platinum(IV) and platinum(II) anticancer complexes with biologically active releasable ligands
Pavel Štarha, Radka Křikavová
Coordination Chemistry Reviews (2023) Vol. 501, pp. 215578-215578
Closed Access | Times Cited: 22

An overview of recent advancements in anticancer Pt(IV) prodrugs: New smart drug combinations, activation and delivery strategies
Carlo Marotta, Ester Giorgi, Francesca Binacchi, et al.
Inorganica Chimica Acta (2023) Vol. 548, pp. 121388-121388
Open Access | Times Cited: 19

Anticancer Activity of Metallodrugs and Metallizing Host Defense Peptides—Current Developments in Structure-Activity Relationship
Celia María Curieses Andrés, José Manuel Pérez de la Lastra, Elena Bustamante Munguira, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7314-7314
Open Access | Times Cited: 7

Small molecule– and peptide–drug conjugates addressing integrins: A story of targeted cancer treatment
Jannik Paulus, Norbert Sewald
Journal of Peptide Science (2024) Vol. 30, Iss. 7
Open Access | Times Cited: 6

Page 1 - Next Page

Scroll to top